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STEM CELLS:
POTENTIAL CURES OR ABORTION LURES?
Valerie J. Janosky*
INTRODUCTION
The controversy over whether scientists should use aborted fetal tissue
for pioneering medical research is heavily debated, and generally
centers on the ethical and moral dilemma of the tissue source versus the
benefits of possible antidotes for many debilitating diseases. Hence,
the question then becomes, "Does stem cell research result in the
destruction of life, or is it the harbinger of a lifesaving scientific tool?",
Opponents argue that fetal stem cell research is immoral, lures women
to have abortions and should therefore be stopped. Advocates, on the
other hand, contend that this "argument threatens to undermine stem
cell studies just at the moment when the promising technology is
making rapid gains." 2 They defend the acquisition of stem cells from
aborted fetuses or from the fertilization of a human egg in a test tube,
because of the cells' unique ability to repair tissue,3 which holds much
promise for new treatments and potential cures.
Essentially, this article will explore the scientific and moral debate
enveloped in the use of fetal stem cells in medical research, the angst
felt amongst both a heavily divided medical community and the reasons
Valerie J. Janosky currently works at a law firm in California. She holds a B.A. degree
from Michigan State University, a J.D. degree from Michigan State University/Detroit College
of Law and a LL.M. degree from DePaul University College of Law. The author wishes to
thank Nancy Shalowitz, M.H.A., J.D. for her much appreciated critique of this article.
1 WebMd, reviewed by Dr. Michael W. Smith, Abortion Debate Clouds Future of Stem
Cell Research (Jan. 26, 2001), at http://my.webmd.com/content/article/1691.51004.
2 ld.
3 Dan Ferber, Ph.D., Ethicists Divided Over Human Embryo Research - Existing Cells
OK to Use, but Don't Make New Ones, Some Say (Feb. 22, 2000), at
http://my.webmd.com/content/article/178.55182.
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why fetal stem cell research is a vital avenue that should be continued
and supported by health law legislation. Additionally, this paper will
provide a scientific background of the use of stem cells, along with the
most recent technological advances, the distinctive nature of these cells,
treatments derived from this new medical option, legislative and
political entanglements resulting from this issue, arguments
surrounding the sources that supply fetal stem cells and the viability of
suggested alternatives.
Fetal tissue research includes numerous studies on the cutting edge
of medical discovery, such as treatments for Parkinson's Disease,
diabetes, Alzheimer's disease, leukemia, AIDS, 4 strokes, spinal cord
injury,5 Huntington's chorea, hemophilia, leukemia, sickle cell anemia,
muscular dystrophy, 6 Tay-Sachs, 7 and cancer among other conditions
where stem cells are being used to replace damaged or dead cells in
8humans. Moreover, in May of 2000, "researchers showed that brain
stem cells could be used to form cells that could treat multiple sclerosis
and a variety of serious nerve diseases." 9 In June of that same year,
"they turned brain stem cells into heart, gut, and liver cells."' 1
Researchers are also trying to use stem cells for bone and cartilage
formation, in addition to therapies targeting heart and kidney
conditions." Currently, clinical trials are "already underway using
bone marrow stem cells to regrow and replace bone that had to be
removed from bone cancer patients." 12  Using fetal tissue in AIDS
studies "gives researchers a working model of the human immune
system for studying viruses,' 13 which may eventually be instrumental
in a cure for AIDS.
4 Don Colburn, The Fetus: Medicine, Law and Morality, WASH. POST HEALTH, Oct. 18,
1988, at 17.
5 Dan Ferber, Ph.D., reviewed by Dr. Aman Shah, Stem-Cell Therapies Inch Their Way
Closer to the Clinic - But First Treatments Still Several Years Away (Aug. 18, 2000), at
http://my.webmd.com/content/article/1728.60509.
6 Planned Parenthood Federation of America, Inc., Donating Fetal Tissue for Medical
Treatment and Research, (Feb. 2000)., at http://www.plannedparenthood.org/library/
facts/fetaltis 010600.html.
7 National Tay-Sachs & Allied Disease Association of Delaware Valley, What is Tay-
Sachs Disease?, at http://www.tay-sachs.org/whatista.htm (last visited Jan. 10, 2003).
8 Sean Martin, reviewed by Dr. Michael W. Smith, Steni Cell Controversy Draws Celebs
to Capitol Hill (Sept. 14, 2000) at http://my.webmd.com/printing/article/1728.61328.
9See Ferber, supra note 5.
10 Id.
1lid
12 [d.
3 See Colbum, supra note 4.
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TOPICS CONCERNING FETAL TISSUE AND STEM CELLS
Background on Fetal Tissue Research and Use
Historically, fetal tissue research and use reaches as far back as to the
1920s. 14  Researchers began transplanting fetal tissue into patients
suffering with diabetes as early as 1928.15 Even though some first
experiments were unsuccessful, the "importance and curative potential
of fetal tissue" became apparent to both the scientific and medical
communities. 16  Since the 1930s, human fetal tissue research and
transplantation have been commonly used in U.S. medical research.
17
In fact, human cell lines have been used to examine the "biochemical
and physiologic processes in normal human development, investigate
disease causing viruses and study the cancer induction."', 8 During the
1950s and 1960s, vaccines for poliomyelitis and rubella, Rh
incompatibility treatment, and prenatal diagnosis of genetic diseases
were developed through fetal tissue research. 19
From a scientific perspective, as the human embryo grows, the
early cells start dividing and forming different kinds of cells, i.e., heart
cells, bone cells, muscle cells, etc., and are called stem cells.2 0 Doctors
could use these early cells to repair "diseased cells virtually anywhere
in the body."21 "Starting with human embryos the size of a pencil dot
on a piece of paper, scientists have extracted primitive stem cells,...
[and] [t]hen have been able to cultivate and multiply these building-
block cells as they develop into more specialized cells. ' ' 22 As a result, a
physician would augment a patient's damaged cells with new, healthy
ones.
23
14 Paul Likoudis, At Home in the Culture ofDeath... Dead Baby Parts Business Booming
(Oct. 28, 1999), available at http://www.freerepublic.com/formula/a37f3c9b331al.htm, citing
Judie Brown, Recycling Babies: The Practice of Fetal Tissue Research (1996).
15 See Donating Fetal Tissuefor Medical Treatment and Research, supra note 6, citing
Mary Carrington Coutts, Fetal Tissue Research, 3 KENNEDY INST. ETHICS J., 81-101 (1993).
16 id.
17 Patricia Schrock, Fetal Tissue Transplantation (Winter 1997), at
http://www.hsc.missouri.edu/-shrp/ radsci/fetal/fetall.html, citing Alan Fine, Transplantation
ofFetal Cells and Tissues: An Overview, CAN. MED. ASS'N J., 1261-68 (1994).
18 Id.
19 See Schrock, supra note 17, citing Lee Sanders et al., Ethics of Fetal Tissue
Transplantation, W. J. MED. 401 , (1993).
20 See Ferber, supra note 5.
21 id.
22 See Martin, supra note 8.
23 Gregory Pence, Ph.D., The Lifesaving Promise of Cloning Technology (Sept. 29,
2000) at http://my.webmd.com/content/article/1691.50913.
2002]
DEPAUL JOURNAL OF HEALTH CARE LAW
Current Technology
In the last twenty years, substantial progress in fetal tissue
transplantation (FTT) as a means of medical therapy has improved
because of better laboratory techniques and an increased understanding
of the practice. 24  Subsequently, women and men worldwide have
received transplanted fetal tissue, and "research has been conducted in
Australia, Canada, China, Cuba, the former Czechoslovakia, Finland,
France, Germany, the United Kingdom, Hungary, India, Italy, Mexico,
Norway, Russia, Spain, Sweden, and Yugoslavia.,
25
Recently, the biomedical pioneer, Geron Corporation of Menlo
Park, California, acquired the company created by Scotland's Roslin
Institute, which cloned "Dolly", the first genetically engineered
26
sheep. This acquisition by Geron combines three new technologies:
"somatic cell nuclear transfer (used to clone Dolly), derivation of cells
called human pluripotent stem cells," (used to regenerate diseased
tissues because of a "natural ability to transform into any type of cell in
the body and to multiply"), and telomerase (keeps cells alive and
dividing beyond their normal life span). 27  Within five years, these
technologies could make it possible for humans to replace diseased
cells by cloning themselves and obtaining stem cells from their own
pre-embryos. 28 Basically, the pre-embryo consists of a blastocyst, a
ball of tiny cells, and does not have any distinguishing features such as
organs, limbs, or a nervous system. 29  Based. upon one's religious
affiliation, this pre-embryo may or may not be considered human life,
thus creating a significant ethical dilemma. However, Judie Brown,
president of the American Life League (ALL), says, "The word pre-
embryo is a false term . . . an embryo is an embryo at fertilization -
period.'3°
Nonetheless, researchers funded by Geron became the first to
acquire the human pluripotent stem cells from donated embryos and
24 See Schrock, supra note 17, citing Daniel Garry et al., Sounding Board: Are There
Really Alternatives to the Use of Fetal Tissue from elective Abortions in Transplantation
Research?, NEW ENG. J. MED., 1592 (1992); Charles Baron, Fetal Research: The Questions in
the States, HASTINGS CTR. REP. 12-13 (1985).
25 See Donating Fetal Tissue for Medical Treatment and Research, supra note 6.
26 Tim Friend, Gov't Oks Fetal Tissue Research (May 23, 1999) at
http://www.lougehrigsdisease.net/als-news/990524govt oks fetaltissueresearch.htm.
27 id.
28 id.
29 See Friend, supra note 26.
30 id.
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fetal tissue. 31 However, two main obstacles must be overcome before
these cells can become a useful therapy:
"First, researchers must learn to coax these cells down
different paths toward becoming heart cells, brain cells or
whatever cell is desired. Geron-funded researchers have been
able to coax their cells into two different types so far - heart
and brain. Second, if these cells are derived from donated
embryos and fetal tissue, they will be rejected by the patient's
immune system just like donated organs. To make these
sources viable for treatment, scientists must learn to make the
cells compatible."32
Additionally, Ronald Eastman, president of Geron in 1999, said
that because of ethical concerns, the company researchers would first
explore other methods of creating these cells from a patient's own
DNA, and would compensate the Roslin Institute $20 million dollars
over the next six years to research ways to develop therapeutic cells
without creating pre-embryos. 33 "That research will focus on a cloning
phenomenon called reprogramming, which refers to the mysterious
ability of an egg cell to reprogram the DNA taken from an adult cell so
that it behaves as if it were at an embryonic stage." 34 If the researchers
are successful at recognizing the signals involved in reprogramming,
"then it may become possible to reprogram the DNA of any cell and
apply that knowledge to creating therapeutic cells without creating an
embryo., 35 If they are not successful, then the next possible jump is for
patients to clone themselves in order for technicians to extract stem
cells from the pre-embryo, or blastocyst. 36 Basically, scientists would
"remove that cell's nucleus and insert it into a donated egg that has had
its nucleus removed, creating an entirely new embryo." 37  This
procedure is called therapeutic cloning, and is different from
reproductive cloning, which would involve implanting a pre-embryo
into a womb in order to produce a child.38
3id.
32 id.
33 id.
34 See Friend, supra note 26.
35 id.
36 See Friend, supra note 26.
37 See Pence, supra note 23.
38 See Friend, supra note 26.
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Uniqueness of Fetal Tissue
At the onset, it is crucial to note two points: first, the terms fetus and
fetal are the proper scientific and legal categorizations of an embryo at
Week 8 of the gestation period,39 and second, "fetal tissue has several
properties that make it particularly useful and unique for
transplantation, and superior to adult (mature) tissues:
" Fetal cells are capable of proliferating faster and more
often than mature, fully differentiated cells; [therefore],
these donor cells are able to quickly reverse the lost
function of the host.
" Fetal cells can often differentiate in response to the
environmental cues around them, [and] because of their
location, they can grow, elongate, migrate and establish
functional connections with other cells around them in the
host.
" Fetal tissue is not as easily rejected [(as adult cells are)] by
the recipient due to the low levels of histocompatibility
antigens, . . . [and] at the same time, angiogenic and
neurotrophic factors are at high levels, enhancing their
ability to grow once they are transplanted.
" Early fetal hematopoietic tissue lacks lymphocytes;
[therefore,] "graft vs. host" reactions are minimized.
" Fetal cells tend to survive excision, dissection and grafting
better because they generally do not have long extensions
or strong intercellular connections.
" Fetal tissues can survive at lower oxygen levels than
mature cells [making them] more resistant to the ischemic
conditions found during transplantation or in vitro
situations. 4 °
Furthermore, since these fetal cells are extremely adaptable and less
likely to be rejected by a transplant recipient, the need to locate difficult
exact tissue matches is significantly reduced a1  Additionally, "fetal
39 See Jeremy Manier, U.S. Quietly OKs Fetal Stem Cell Work Bush Allows Funding
Despite Federal Limits On Embryo Use, Cm. TRIB., July 7, 2002, § I at 1.
40 See Schrock, supra note 17, citing Robert Hurd, Ethical Issues Surrounding the
Transplantation of Human Fetal Tissue, CLINICAL RESEARCH 661 (1992), and Alan Fine,
Transplantation of Fetal Cells and Tissues: An Overview, CAN. MED. ASS'N., 1261 (1994).
41 See Donating Fetal Tissue for Medical Treatment and Research, supra note 6, citing
Mary Carrington Coutts, Fetal Tissue Research, 3 KENNEDY INST. ETHICS J. 81-101 (1993), and
Rick Weiss, Stem Cell Discovery Grows Into A Debate, WASH. POST, Oct. 9, 1999, Al.
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tissue is easier to culture in the laboratory and in greater supply than
adult tissue.",
42
Fetal Research for Specific Diseases
The unique characteristics of fetal tissue have led to "FTT experiments
for the treatment of several human diseases that were once thought to
be irreversible or incurable." 43  Fetal tissue transplants have been
promising for patients suffering from Alzheimer's disease, spinal cord
and other neural tissue injuries, diabetes, some forms of blindness, and
are used to treat blood-clotting disorders, such as sickle cell anemia,
thalassemia, and hemophilia,44 just to name a few. Moreover, fetal
liver cells may be useful in treating leukemia and aplastic anemia.
45
Parkinson 's Disease
Considered one of the most common crippling diseases in the country,
Parkinson's Disease is a chronic nervous disease exemplified by a slow
tremor, rigidity, and muscular weakness. 46 Primarily, these symptoms
are caused by the decrease production of dopamine, a neurotransmitter,
by cells in the substantia nigra area of the brain. While the disease
affects men more than women, it can afflict young people, and is found
in I in every 100 persons over the age of 60.48 Generally, a person
suffering from Parkinson's will continue to deteriorate for an average
of 10 years, and then will commonly die from aspiration pneumonia or
some other infection.49
42 id.
43 Patricia Schrock, Fetal Tissue Transplantation (Winter 1997), at http://www.hsc.
missouri. edu/ -shrp/ radsci/fetal/fetall.html, citing Stanley Loeb, DISEASES AND DISORDERS
HANDBOOK 550 (Springhouse Corp. 1988).
44 See Donating Fetal Tissue for Medical Treatment and Research, supra note 6.
45 Id.
46 See Schrock, supra note 43.
47 Patricia Schrock, Fetal Tissue Transplantation (Winter 1997), at http://www.hsc.
missouri.edu/-shrp/ radsci/fetal/fetal lhtml, citing Alan Fine, Transplantation of Fetal Cells
and Tissues: An Overview, CAN. MED. ASS'N., 1264-65 (1994); Olle Lindvall, Clinical
Applications of Neural Grafts in Parkinson's Disease, J. NEUROLOGY 554-56 (1994); J. Lopez
et al., Long Term Follow-Up in 10 Parkinson's disease Patients Subjected to Fetal Brain
Grafting into a Cavity in the Caudate Nucleus: The Clinica Puerta de Hierro Experience,
TRANSPLANTATION PROCEEDINGS 1395-1400 (1995).
48 Patricia Schrock, Fetal Tissue Transplantation (Winter 1997), at
http://www.hsc.missouri.edu/-shrp/ radsci/fetal/fetal I.html, citing Stanley Loeb, DISEASES AND
DISORDERS HANDBOOK 550 (Springhouse Corp. 1988).
49 id.
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While it is still in the experimental stages, the use of fetal tissue
shows great promise in many treatment areas.50  One of these
procedures involves the transplantation of human fetal brain cells into
patients suffering with Parkinson's Disease in order to restore their
motor function. 51  This might be done surgically by injecting a liquid
containing the cells 52 thereby transplanting the newly developed tissue
into a patient's brain. 53  These implanted fetal neurons can replace
"dead host neurons, form effective synapses with host neurons, and
produce the necessary neurotransmitters." 54 In fact, "[t]he number of
implanted dopaminergic cells needed for recovery of movement
represents only about one-tenth of a million of the total number of
nerve cells in the brain. 55
While the clinical teams that perform these procedures differ in
both their success and transplantation methods, promising results
from FTT studies in humans with Parkinson's Disease have shown
improved symptoms with the utilization of all implantation
techniques. 57 These studies reported that "fetal tissue transplantation
does improve self-assessed quality of life; it decreases the frequency
and intensity of 'freezing spells' - a characteristically disabling feature
of the disease - and decreases the required dosage of levodopa.
'58
However, another study by Dr. Curt Freed, the principal
researcher in the University of Colorado Health Sciences Center,
50 See Donating Fetal Tissue for Medical Treatment and Research, supra note 6, citing
Mary Carrington Coutts, Fetal Tissue Research, 3 KENNEDY INST. ETHICS J., 81-101 (1993),
and Rick Weiss, Stem Cell Discovery Grows Into a Debate, WASH. POST, Oct. 9, 1999, at Al,
and National Institutes of Health, Withdrawal of Interim NIH Guidelines for the Support and
Conduct of Therapeutic Human Fetal Tissue Transplantation Research in Light of Superseding
provisions of Public Law.
51 id.
52 Ole Isacson, M.D., Ph.D., On the Brain. Fetal Nerve Cell Transplantation: Advances
in the Treatment of Parkinson 's Disease, (The Harvard Mahoney Neuroscience Institute Letter)
(1994), available at http://neurosurgery.mgh.harvard.edu/oisacson.htm.
53 See Pence, supra note 23.
54 See lsacson, supra note 52.
55 Id.
56 id.
57 See Schrock, supra note 47.
58 Patricia Schrock, Fetal Tissue Transplantation (Winter 1997), at
http://www.hsc.missouri.edu/-shrp/ radsci/fetal/fetall.html, citing Lee Sanders et al., Ethics of
Fetal Tissue Transplantation, W. J. MED., 401 (1993); J. Lopez, et al, Long Term follow-up in
10 Parkinson 's Disease Patients Subjected to Fetal Brain Grafting into a Cavity in the Caudate
Nucleus: The Clinica Puerta de Hierro Experience, TRANSPLANTATION PROCEEDINGS 1395-
1400 (1995); and Olle Lindvall, Clinical Applications of Neural Grafts in Parkinson's Disease,
J. OF NEUROLOGY 555 (1994).
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concluded that people who were less than 60 years old and suffering
from Parkinson's significantly improved when they received a
transplant of brain cells from aborted fetuses that developed to their
seventh or eighth week. These cells began to produce dopamine, a vital
neurochemical that is grossly deficient in Parkinson's Disease
sufferers. 59 However, in patients over 60, the treatment was not very
effective. 60
Dr. Gerald Fischback, the Director of the National Institute of
Neurological Disorders and Stroke, which funded the study said, "I
think the findings are extremely promising. My view is that the surgery
worked. The cells took. They survived, they were manufacturing the
transmitter dopamine." 61  While it is true that the tissue used in the
research for Parkinson's Disease does not survive for very long in its
new host, symptoms decrease or even reverse themselves for a short
time after the transplantation.
62
Diabetes
Diabetes mellitus, a chronic disease of insulin deficiency or resistance,
is a leading cause of death in the United States, according to the
Diseases and Disorders Handbook.63  This disease is also the leading
cause of new blindness, and contributes to about 50 % of myocardial
infarctions and approximately 75 % of strokes. 64 Moreover, it is the
seventh leading cause of death in the U.S. 65  In fact, one in every
twenty Americans, which translates into about 16 million people, suffer
from a blood sugar imbalance. 66 "Diabetes is a prime target for FTT,
59 Daniel Kennelly, Fed Funded Fetal Tissue Research Rekindles Controversy, (Apr. 29,
1999) at http://www.cnsnews.org/InDepth/archive/I99904/ND I9990429d.html.
60 Id.
61 Id.
62 Emma Kirby-Glatkowski, Use of Fetal Tissue Research to Cure/Treat Neurological
Disorder, (Apr. 29, 1999) at http://www.conservativenews.net/InDepth/archive/
199904/IND 19990429d.html.
63 Patricia Schrock, Fetal Tissue Transplantation, at 225 (Winter 1997), at
http://www.hsc.missouri.edu/-shrp/ radsci/fetal/fetal 1 .html.64
1d..
65 Michael Gonzalez, D.Sc., Ph.D., FACN, Blood Sugar Levels: Are Stem Cells the
Answer to Blood Sugar Problems?, 7 J. LONGEVITY 21-23, (2001), citing American Diabetes
Association, Diabetes Facts and Figures (2000) at http://www.diabetes.org/
main/info/facts/facts.jsp (last visited Jan. 13, 2003).
66 See Gonzalez, D.Sc., Ph.D., FACN, Blood Sugar Levels: Are Stem Cells the Answer to
Blood Sugar Problems?, 7 J. LONGEVITY 21-23, (2001), citing R. Eisner, R., A breath offresh
insulin: Inhaled insulin lowers blood sugar in a small study of diabetics (2001)
http://more.abcnews.go.com/sections/living/dailynews/insulininhalerO10201 
.html.
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because it is thought that stem cells could be readily converted to cells
that produce insulin." 67 Since standard insulin therapy generally cannot
prevent these complications, early investigators suggested using fetal
pancreatic tissue for the treatment of this disease in order to more
accurately regulate a diabetic's glucose levels. 8 In a study comparing
the two treatments, researchers found that a partial cure of diabetes
resulted from the FTT, and in the long term, retinopathy either stopped
or improved, and renal function remained normal; which is significant
because patients that receive intensive human insulin therapy are
inclined to increased retinopathy and renal dysfunction.
69
Tay-Sachs
Tay-Sachs is a genetic disease that is transmitted when both parents are
Tay-Sachs gene carriers, giving the defective gene to their child.7°
Children develop Tay-Sachs by inheriting two Tay-Sachs genes (one
from each parent), and as a result, lack the hexosaminidase A (Hex-A)
enzyme. 71 Hex-A is vital for the body to "break down a fatty waste
substance found in brain cells; without this enzyme, the waste
accumulates abnormally and causes progressive damage until the
nervous system can no longer sustain life."
72
"A baby with Tay-Sachs disease appears healthy at birth, and
seems to be developing normally for a few months.
Symptoms generally appear by six months of age. While
symptoms vary from one child to the next, there is always a
slowing down of development. Gradually, Tay-Sachs
67 Abortion Debate Clouds Future of Stem Cell Research, supra note 1.
68See Patricia Schrock, Fetal Tissue Transplantation (Winter 1997), at
http://www.hsc.missouri:edu/-shrp/ radsci/fetal/fetall.html, citing Alan Fine, Transplantation
of Fetal Cells and Tissues: An Overview, CAN. MED. Ass' J. 1262-63 (1994); G. Farkas et al.,
Long Term Effects of Fetal Islet Transplantation on Complication of Diabetes, as Compared
with Effects of Intensive Insulin Therapy, TRANSPLANTATION PROCEEDINGS 3145 (1995).
69 Patricia Schrock, Fetal Tissue Transplantation (Winter 1997), at
http://www.hsc.missouri.eduL/-shrp/ radsci/fetal/fetall.html, citing G. Farkas et al., Long Term
Effects of Fetal Islet Transplantation on Complication of Diabetes, as Compared with Effects of
Intensive Insulin Therapy, TRANSPLANTATION PROCEEDINGS 3145 (1995); K.J.. Lafferty § L.
1-ao, Fetal Pancreas Transplantation for Treatment of IDDM Patients, DIABETES CARE 33-86
(1993); P.B. Dordevic et al., Human Fetal Islet Transplantation in IDDM Patients: An 8-year
Experience, TRANSPLANTATION PROCEEDINGS, 3146-47 (1995).
70 National Tay-Sachs & Allied Disease Association of Delaware Valley, What is Tay-
Sachs Disease?, http://www.tay-sachs.org/whatista.htm (last visited Jan. 10, 2003).
71 lId
72 Id.
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children lose motor skills and mental functions. Over time,
the child becomes blind, deaf, mentally retarded, paralyzed
and non responsive to the environment. Tay-Sachs children
usually die by age five."73
By using a cloning method, Harvard University researchers have
derived some very significant results for treating Tay-Sach's disease. 74
Essentially, they have been able to stop the progression of the disease
and even reverse it by genetically engineering cells to produce the
missing protein that causes this disease by introducing it to the deficient
Tay-Sach's cells."
75
Spinal Cord Injury
Traditionally, human fetal spinal cord cells are grafted into the cystic
cavity of a patient suffering with syryngomyelia, or expanding cysts.
76
Currently, the outcome is not to cure spinal cord injury, but to impede
the loss of sensory and motor function from these cysts. 77 The cavity is
drained and the liquid is replaced with tissue. 78  There have been
numerous animal experiments with fetal tissue, and the results
indicated that "some paralyzed cats recovered function after fetal tissue
treatment, without harm to the animals., 79 Scientists are hopeful they
can achieve similar results with humans.
Other Diseases
Huntington's Disease, Alzheimer's Disease, Friedreich's Ataxia,
intractable epilepsy and stroke sufferers may benefit from fetal tissue
transplantation, as indicated by some animal experiments.80
Additionally, blood disorders such as aplastic anemia, hemophilia and
leukemia, immunodeficiency caused by congenital absence of thymus
and parathyroid tissue (Di George Syndrome) and blindness (age
73 Id.
74 Kirby-Glatkowski, supra note 62.7 5 
id.
76 Scientists to Treat SCI with Fetal Tissue, NEW MOBILITY MAG., Jan. 1997.77
1d.
7 8 id.
79 id.
so Patricia Schrock, Fetal Tissue Transplantation (Winter 1997), at
http://www.hsc.missouri.edu/-shrp/ radsci/fetal/fetall.html, citing Alan Fine, Transplantation
of Fetal Cells and Tissues: An Overview, CAN. MED. ASS'N., 1264-65 (1994); Y.J. Li et al.,
Transplantation of Cholinergic-rich Spinal Tissue from Spontaneously Aborted Human Fetuses
Into a Rodent Model ofAlzheimer's Disease, TRANSPLANTATION PROCEEDINGS 3336-67 (1994).
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related macular degeneration) are other areas where FTT may be an
effective treatment. 81
AIDS Research From Fetal Tissue
Notably, much of the fetal tissue available for research is used for
HIV/AIDS studies involving SCID-hu mice, 82 and this research
continues to receive support from the AIDS community. "The AIDS
interest in human fetal transplantation stems largely from a paper on
thymic transplantation published in 1987 by researchers at the Yale
University School of Medicine," even though the tissue came from
young children who had to have part of their thymus removed during a
heart operation.
83
"it was transplanted into 15 volunteers with advanced AIDS;
the transplanted tissue survived, for several months at least, in
eight of them. Remarkable clinical improvements occurred in
some cases, although as expected the benefit appeared to be
temporary. Nine patients showed clinical improvement two
months after the operation (including one in whom live
transplanted cells were not found). The most dramatic case
was one patient in which cytomegalovirus retinitis appeared
to resolve spontaneously with no other treatment.
T8 cells (a kind of T-cell, different from T-helper cells, which
also may be important in controlling the AIDS virus) showed
substantial increases in all eight of the patients in whom the
transplant was successful, more than doubling in every case,
and often increasing several fold. T-helper increases,
however, were small.' 84
8'Patricia Schrock, Fetal Tissue Transplantation (Winter 1997), at
http://www.hsc.missouri.edu/-shrp/ radsci/fetal/fetall.html, citing P.V. Algvere et al,
Transplantation of Fetal Retinal Pigment Epithelium in Age-related Macular Degeneration
with Subfoveal Neovascularization, GRAEFS ARCHIVE FOR CLINICAL AND EXPERIMENTAL
OPHTHALMOLOGY 707-716 (1994); Lee Sanders et al., Ethics of Fetal Tissue Transplantation,
W. J. MED. 400-1 (1993); Alan Fine, Transplantation of Fetal Cells and Tissues: An Overview,
CAN. MED. Ass'N J.., 1261- 65 (1994).
82 Paul Likoudis, At Home in the Culture of Death... Dead Baby Parts Business Booming,
(Oct. 14, 1999) at http://www.freerepublic.com/formula/a37f3c9b33 I al .htm.
83 John S. James, Fetal Tissue Research Background, AIDS TREATMENT NEWS, Dec. 4,
1992, at 7.
84 Id.
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The SCID-hu Mouse: Mice with Transplanted Immune Systems
Subsequently, researches began to feel that "gene therapy of human T-
lymphocyte disorders, especially acquired immunodeficiency syndrome
(AIDS), would be greatly facilitated by the development of an in vivo
system in which transduced human hematopoietic stem cells are used to
reconstitute the T-lymphoid compartment,"8 5 by using a SCID-hu
mouse. These mice are born with severe combined immune deficiency
(SCD), due to a genetic defect, then are successfully given a human
immune system by transplantation of human fetal thymus and liver
tissue.86 "Briefly, a SCID mouse is engrafted with either a human bone
marrow fragment, thymus/liver graft, or a lymph node." 87 As a result,
these mice can be infected with HV,88 and are used to study
hemoglobinopatheis.8 9 Proponents for this type of research contend
that this will blaze the trail for thymus transplants that could strengthen
the ADS patient's immune systems.
90
Since the medical community discovered that the "transplantation
of fetal liver hematopoietic stem cells (HSCs) in utero had the potential
to treat a variety of hematologic, immunologic, and metabolic
diseases," 91 a few of their contemporaries developed methods for
"processing fetal liver free of known human pathogens while
maximizing HSC activity after cryopreservation," (a method of long
term storage of cells or tissues by freezing them in such a way as to
minimize ice crystal formation).92 They used human fetal livers from
aborted specimens that gestated about 12 to 14 weeks and isolated the
hematopoietic cells. 93  Additionally, these researchers developed a
protocol that separated the abortion decision from the donation
decision, preserving the confidentiality between the donor and
85 Ramesh K. Akkina et al., Modeling Human Lymphoid Precursor Cell Gene Therapy in
the SCID-hu Mouse, 84 BLOOD 1393 (1994).
86 Nancy Solomon, AIDS: Of Mice and Men, ADVOCATE (CDC HIV/AIDS, STD, TB:
PREVENTION NEWS UPDATE), Dec. 29, 1992, at 70.
87 Likoudis, supra note 82.
81 See Solomon, supra note 86.
89 Likoudis, supra note 82.
90 See Solomon, supra note 86.
91 George B. Mychaliska et al., The Biology and Ethics of Banking Fetal Liver
Hematopoietic Stem Cells for in Utero Transplantation, 33 J. PEDIATRIC SURGERY 394-99
(1998).
92 Robin Geller, Re: How Does Cryopreservation Work? (October 1998), at
http://www.madsci.org/posts/archives/oct98/908221290.Cb.r.html (last visited Jan. 13, 2003).
93 See Mychaliska et al., supra note 91.
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recipient. 94  Consequently, they concluded that their research
demonstrated human fetal liver cells (HSCs) can be ethically obtained
and "processed to ensure a graft with a small number of T-cells and a
high yield of progenitors after cryopreservation," and they stated that a
bank of fetal liver HSC would treat various genetic diseases before
birth by in utero transplantation.
95
Organ Transplants
"All 50 states and the District of Columbia have adopted some form of
the Uniform Anatomical Gift Act (UAGA), which gives people the
right to control the disposition of their bodily remains after death, and
is usually interpreted to permit fetal tissue donation." 96 Donees must
give written consent for their donation, entire body or body parts, to be
used for any type of research, education, therapy, or transplantation.
97
Most states permit fetal tissue and organ donations; however, there are
some state legislatures that single out fetuses and exclude them from
the UAGA legal provisions.
98
"In 1997, the United Network of Organ Sharing reported 3,565
children and 76,526 adults were waiting for organ transplants." 99 In
fact, more than 4,000 people die each year waiting for one.1"0 Cloning
could possibly produce whole organs, i.e., hearts, lungs, livers, kidneys,
etc., giving hope to these people and a new lease on life, but only if
human cloning and related technologies are allowed to proceed. 101
Gregory Pence, Ph.D., a professor of philosophy in the medical
school at the University of Alabama in Birmingham, and author of Re-
Creating Medicine: Ethical Issues at the Frontiers of Medicine
(Rowman & Littlefield), believes that embryonic stem cell research has
created many new possibilities, and that in the future, embryo cloning
could be used to replace damaged or diseased organs without having
the recipients undergo the risk of organ rejection (because the organs
94 id.
95 id.
96 Planned Parenthood Federation of America, Inc., Donating Fetal Tissue for Medical
Treatment and Research (Feb. 2000), at http://www.plannedparenthood.org/library/
facts/fetaltis_010600.html, citing Vawter ct al, The Use of Human Fetal Tissue: Scientific,
Ethical, and Policy Concerns, U. MINN. CTR. FOR BIOMEDICAL ETHICS (1990).
97 d
98 Id.
99 See Pence, supra note 23.
100 Id.
101 Id.
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would be created from their own genetic material), and the prolonged
use of anti-rejection drugs that accompany most standard organ
transplants. 
102
Legislative History
"In 1973 the U.S. Supreme Court legalized first and second trimester
abortions in Roe v. Wade. 103 This landmark decision spurred the legal
controversy and public concern regarding fetal tissue research within
American society, "primarily due to the fact that much of the fetal
tissue used in research and transplantation was from elective
abortions."' 1 4 But by this time, most states had enacted various forms
of legislation to regulate fetal research and transplantation within their
respective jurisdictions, and all 50 states had enacted the UACA
governing the donation and use of all or part of the human body of
adults, children, and fetuses.
10 5
In 1974, the National Commission for the Protection of Human
Subjects of Biomedical and Behavioral Research was established
within HEW, the former U.S. Department of Health, Education, and
Welfare (now the Department of Health and Human Services, or
DHHS)" 0 6 in order to scrutinize fetal research. 10 7 After its review,
HEW stipulated that the research in question be permitted in accord
with state law, and subsequently, issued regulations on the matter. 10
8
Fetal research progressed for the next 10 years, until "the New England
Journal of Medicine reported the successful transplantation of fetal
neural tissue into the brains of two young patients with Parkinson's
Disease,"'10 9 and researchers began to request federal funding for
further fetal tissue projects. 1 0
102 See id.
0o3 See Schrock, supra note 24.
104 id.
105 Patricia Schrock, Fetal Tissue Transplantation (Winter 1997), at http://www.hsc.
missouri.edu/-shrp/ radsci/fetal/fetall.html, citing Charles Baron, Fetal Research: The
Question in the States, HASTINGS CTR. REP. 12-13 (1985); Mary Mahowald et al., The Ethical
Options in Transplanting Fetal Tissue, HASTINGS CTR. RE'. 10 (1987); Henry Greely et al,
Special Report: The Ethical Use of Human Fetal Tissue in Medicine, NEW ENG. J. MED. 1093
(1989).
06 Donating Fetal Tissue for Medical Treatment and Research, supra note 15.
log Id.
109 Id.
110 Id.
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Soon after, anti-abortion activists created inflammatory and
alarming misinformation, campaigning for a ban on "all federally
funded research involving the transplantation of tissue from induced
abortions into humans."1 1' Moreover, during the Reagan-Bush
administration, the president and his supporters argued that advances in
this area of treatment would create new incentives for having an
abortion, and might actually lead to more abortions. 112 While leading
experts on the 1988 National Institutes of Health (NIH) Fetal Tissue
Transplantation Research Panel objected," 3 the DHHS placed a
moratorium upon federally funded fetal tissue research 1 4 even though
the specimens were obtained from elective abortions. These experts
consisted of members assembled by the NIH which, in turn,
recommended that the moratorium be lifted," 5 "supporting fetal tissue
transplantation research as 'acceptable public policy.' 116 They argued
that "sufficient separation could be made between a woman's decision
to abort and the use of the tissue for research.", 1 17 Essentially, the panel
agreed upon standards which prevented the medical use of fetal tissue
from causing any pressure on women to have an abortion by forbidding
any payment for the tissue, and any directed donation to a particular
patient, i.e., one who might be a friend of the donor or have arranged
for payment on the side."
18
However, opponents of fetal tissue research contended that "the
NIH director, who appointed the panel, was publicly predisposed in
favor of fetal tissue research,"' 19 thereby influencing the outcome of the
panel's recommendation. They also claimed that another NIH panel,
which declared that fetal research should only be done on embryos up
to 20 days old, comprised a majority of people directly involved in the
proposed research. 12  Additionally, anti-abortion groups argued that a
woman's decision to have an abortion could be influenced by another
person possibly benefiting from the use of the fetal tissue, 12 1 even
1 1 Donating Fetal Tissuefor Medical Treatment and Research, supra note 15.
112 Right to Life of Michigan, Fetal Tissue & Embryo Research, at http://www.
rt[.org/html/fetal_tissue embryoresearch.html (last visited Jan. 13, 2003).
113 See Donating Fetal Tissuefor Medical Treatment and Research, supra note 15.
114 id.
15 Right to Life of Michigan, supra note 112.
116 See Donating Fetal Tissuefor Medical Treatment and Research, supra note 15.
... Right to Life of Michigan, supra note 112.
'18 James, supra note 83.
"'9 Right to Life of Michigan, supra note 112.
120 id.
121 See James, supra note 83.
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though the panel accordingly suggested that "procedural safeguards
were needed to insure that the prospect of abortion being socially
beneficent would not influence a woman's decision to abort."
' '22
"Technically, the fetal-tissue ban only prevented Federal funding
of research on transplanting fetal tissue into humans;, 123 and "privately
funded research was being done, as well as federally-funded research
using tissue from spontaneous abortions (miscarriages) and abortions
needed to save the mother's life." 124 This ban did not include other
work with the tissue, such as laboratory studies, but it did "cast a
stigma of federal disfavor over the whole area of fetal tissue research,
causing scientists to avoid promising studies they otherwise would
have conducted"'' 25 had the moratorium never been put into place. It is
important to note that "science is a highly politicized area, mainly
because it is heavily dependent on federal funding, permissions, and
other decisions."' 126  Thus, some scientists and researchers were
"reluctant to even discuss the issue, because they did not want to
become involved in the politics surrounding it." 
127
Unsurprisingly, the administration under George H. Bush
overruled the expert panel set up to examine this issue, as well as an
advisory committee to the director of the NIH. 128 While Congress tried
to overturn the ban through an NIH Reauthorization Act provision,
President Bush vetoed that bill.'2 9  Bush argued the bill was,
"inconsistent with our nation's deeply held beliefs."'' 30  As an aside,
President Reagan's moratorium was only a temporary one, 131 and when
President Bush took office, he extended the moratorium indefinitely.' 
32
Christopher Scott, Associate Director of the Arnold and Mabel
Beckman Center for Molecular and Genetic Medicine at Stanford,
opposed President Bush's actions and contended:
122 Right to Life of Michigan, supra note 112.
123 James, supra note 83.
124 Right to Life of Michigan, supra note 112.
125 See James, supra note 83.
126 id.
127 id.
128 Id.
129 id.
130 Christopher Scott, Fetal Tissue Research, 6 THE SCIENTIST (1992).
13 Right to Life of Michigan, supra note 112.
132 See Donating Fetal Tissue for Medical Treatment and Research, supra note 15.
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"In 1987, the National Institutes of Health spent more than
$11 million on fetal tissue research and continued to spend
millions on non-therapeutic research using tissue obtained
legally from either spontaneous or elective abortions,
according to the 'Report of the NIH Ad Hoc Panel on Human
Fetal Tissue Research,' submitted Dec. 14, 1988, to the NIH
director's advisory committee. If, as Bush claims, the issue is
an ethical and philosophical one, why does his administration
permit, even encourage, research using tissue from elective
abortions on one hand and deny it on the other? The
contradiction shows the Bush administration has no high
moral agenda, only a political one."'3
When Bill Clinton took office as president in 1992, his
administration and the NIH Director, Harold Varmus, announced that,
"Stem cells, or master cells, are not covered by the ban on federal
funding of human embryo research, because they are not human
embryos capable of developing into a person."' 134 Pro-life advocates
heavily chastised this declaration as science using another human being
in order to obtain stem cells. 135 Nonetheless, in 1993, Congress lifted
the DHHS moratorium on projects that involved transplanting tissue
from selectively aborted children, 136 and restored their federal funding
by approving the 1993 NIH Revitalization Act. 137  Clinton's
administration made sure that federal research dollars were no longer
prohibited from going to fetal tissue research projects. 138
On December 1, 1994, another NIH committee declared that
various research projects involving the intentional creation of human
embryos for genetic and other research purposes are ethically
acceptable, and indicated that projects which fell within their outlined
parameters should be eligible to receive federal grants. 139  While
Clinton issued a directive prohibiting federal funding to projects
creating new embryos, in essence, the directive did not prohibit the
derivation of embryos created in the in vitro fertilization process. 140
Therefore, embryos fertilized with the intent to create a functioning
113 See Scott, supra note 130.
134 Right to Life of Michigan, supra note 112.
135 id.
136 Id.
137 See Schrock, supra note 24.
138 Right to Life of Michigan, supra note 1 2.
139 Id.
140 Id.
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human being, but as a result could not be viably used, were fair game
for stem cell research.
In 1996, Congress overrode Clinton by passing a bill that
prohibited federal funding of any research on live human embryos.
141
But the tides really began to turn in 1998, when "scientists around the
nation were announcing huge advancements in the area of stem cell
research, which could someday lead to the culturing of new organs"
142
and the curing of diseases that were once thought untreatable. Soon
after, there was a surge of support against the ban on federally funded
human embryo research because it was "slowing down potentially life
saving advancements in the area of stem cell research.' 43  In fact,
"after consulting with scientists and a variety of religious
representatives, the National Bioethics Advisory Committee (NBAC)
recommended that Congress ease its prohibition, primarily because
research funded solely by private companies would not necessarily
generate the knowledge and potential therapies that the public could
otherwise gain."
144
"Some states have enacted laws that ban the use of fetal tissue
for 'experimentation.' Such laws have been struck down as
unconstitutional by federal courts in Illinois, Louisiana, Utah,
and most recently, Arizona. However, laws that ban or
somehow restrict fetal tissue research remain on the books in
several states, including: Indiana, Kentucky, Missouri, New
Mexico, North Dakota, South Dakota, and Tennessee." 145
Current Presidential Administration
The Clinton administration allowed stem cell experiments to proceed
under tight guidelines, but scientists and ethicists alike were unclear
how George W. Bush would proceed with the issue. 146 Mary Hendrix,
Ph.D., President of the Federation of American Societies for
141 Id.
142 id.
14' Right to Life of Michigan, supra note 112.
144 Ferber, supra note 3.
145 See Donating Fetal Tissuefor Medical Treatment and Research, supra note 15, citing
Margaret S. v. Edwards, 597 F. Supp. 636 (E.D. La. 1984), aff'd, 794 F. 2d 994 (5th Cir. 1986);
Lifchez v. Hartigan, 735 F. Supp. 1361 (N.D. Ill. 1990); Jane L. v Bangerter, 794 F. Supp. 1537
(D. Utah 1994), reversed, 61 F. 3d 1493 (10th Cir. 1995); and Forbes v. Woods, No. CV 96-
288 TUC WDB (D. Az., filed April 29, 1996).
146 See WebMd, reviewed by Dr. Michael W. Smith, Abortion Debate Clouds Future of
Stem Cell Research (Jan. 26, 2001), at http://my.webmd.com/content/article/1691.51004.
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Experimental Biology, said that Bush transition team officials told her
organization "precipitous action on the stem cell research was
unlikely." 147 Hendrix responded by saying that if any policy reform
occurs, she hoped to persuade President George W. Bush and his
administration that "stem cell experiments hold great promise and can
proceed in an ethical manner."1 4 8 Not surprising, "a group of 60,000
scientists pushed hard to hold the line on stem cell studies."'
49
Recently, a White House press secretary said, "You're familiar
with the President's position on the issue. If there are any other
regulations or any other changes, you'll be notified," when commenting
on Bush's presidential campaign in support of existing federal policy
that prohibits research involving the destruction of an embryo.
150
"However, since the new president had already rolled back funding for
international family planning programs that counsel or offer abortion
services, the question [became] will Bush take a hard look at stem
cells?" 151
In August of 2001, President George W. Bush answered that
question by announcing that his administration would back partial stem
cell funding.' 52 He stated that the federal government would pay for a
limited amount of research from human embryos, and that while federal
grants may not be used for stem cell studies where the source of the
cells involved the creation or destruction of additional embryos,
funding of projects would be provided for research that involved left
over embryos from fertility clinics, i.e., existing colonies of stem cells.
153 He pointed out that 60 of these colonies, or lines, already exist, and
that he would create a presidential committee to oversee this type of
research. 1
54
President George W. Bush said that since he is an opponent of
abortion, this decision placed him at a "difficult moral intersection.'
55
However, he noted that he made his decision by asking whether frozen
147 id.
148 Abortion Debate Clouds Future of Stem Cell Research, supra note 146.
149 id.
150 id.
151 Id.
152 Amy Goldstein & Mike Allen, Bush Backs Partial Stem Cell Funding, WASH. POST,
Aug. 10, 2001, available at http://www.washingtonpost.com/ac2/wpdyn?pagename=article
&node=&contentld=A56170-2001 Aug9.
153 id.
154 Id.
155 ld.
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embryos are life and should they be protected, and if they are going to
be discarded anyway, should they be used to possibly save or improve
other lives. He concluded that stem cell research "offers both great
promise and great peril,' 56 and therefore knew he had to proceed with
great care. "At its core," Bush said, "this issue forces us to confront
fundamental questions about the beginning of life and the ends of
science."1
57
As expected, President George W. Bush's decision did not go
without criticism whereby some congressional Democrats and
coalitions criticized him for not allowing enough funding. "Once
again, the President has done the bare minimum in order to try and
publicly posture himself with the majority of the Americans.. .But
Americans know this is not the decision that the science community
needs to go forward full force,' 58 said House Minority Leader Richard
A. Gephardt (D-Mo.). Similarly, Dan Perry of the Alliance for Aging
Research stated, "We are saddened that President Bush failed the
leadership test and cast a shadow on the hopes of patients and the
promise of science."
159
Some critics of Bush even come from his own party, as is the case
of Senator Arlen Specter, (R-Pa.), who is co-sponsoring a bill along
with Senator Tom Harkin, (D-Iowa), allowing federal funding to
extract stem cells for research from frozen embryos that are discarded
every year by the thousands. Supporters of this bill are concerned that
the existing stem cell lines would not be enough to meet the needs for
research. Specter intends to press for an early Senate vote on the bill,
but it is not likely he will capture the votes needed to overturn a veto.
1 60
This fear comes from the president's threat that he would do just that if
there was a push for broader stem cell research funding, i.e., extending
funding to embryos that fall outside of the existing 60 lines. 16 1 To add
to the pendulum's swing, Congress could erratically overturn Bush's
policy on stem cell funding, illustrating that the American government
is not without its check and balances, and that this issue is far from
being settled in the legislative branch.
156 Id.
157 Bush Backs Partial Stem Cell Funding, supra note 152.
159 Id.
159 Id.
160 MSNBC News, Specter Urges Broader Funding, (August 13, 2001), at http://stacks.
msnbc.com/news/610311 .asp.
161 MSNBC News, Bush Says He'd Veto Broader Stem Cell Funding (August 13, 2001),
at http://stacks.msnbc.com/news/610311 .asp.
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In respect to related legislation, a question was posed to the U.S.
House of Representatives in the form of a bill asking whether a fetus is
a human being for the purposes of The Unborn Victims of Violence
Act.' 62 Apparently so, as the measure passed by a vote of 252-172,
making it a federal crime to harm a fetus (a member of the species
homo sapiens, at any stage of development who is carried in the womb)
during an attack on a pregnant woman.1 63  This bill does not affect
abortions performed with the woman's consent, and "only deals with
women who have already chosen to carry a pregnancy to term,'
'64
essentially exempting abortion doctors. 165  Had this bill affected
abortions across the board, it may have applied to some forms of tissue
specimens used for fetal tissue research. Currently, as legislative
safeguards, "federal law already states that it is illegal to sell fetal
tissue, providing fines, imprisonment, or both for violations."
' 66
British Legislation for Fetal Tissue Research
The controversy surrounding stem cell research is not limited to the
confines of the United States, but has found its way to the medical,
governmental, and societal communities of other countries. In
particular, England is facing similar scientific and ethical debates, and
has progressed more proactively with legislation to foster research, in
comparison to the conservative approach taken by America. After
researchers turned human brain stem cells into heart, gut, and liver
cells, and bone marrow stem cells into nerve cells, England's
government proposed changing the ban on human cloning in order to
allow scientific research on embryonic stem cells.' 67 "Currently, these
cells are derived from either very early embryos discarded at in vitro
162 Scott Shuger, Fetus Don't Fail Us Now (April 27, 2001), at http://politics.
slate. msn.com/id/1007587.
163 Kaiser Daily Reproductive Health Report, House Passes Unborn Victims of Violence
Act 252-172, Rejects Lofgren Amendnment (April 27, 2001), at http://report.kfforg/
archive/repro/2001/4/kr0 10427.1 .htm.
164 Deborah Zabarenko, House Passes Bill Defining Fetuses As People, REUTERS (April
26, 2001), available at http://dailynews.yahoo.com/h/nm/20020426/ts/congress/_abortion_
dc_2. html.
165 Tom Curry, MSNBC, House Approves Fetal Protection Bill, (April 26, 2001), at
http://www.msnbc.com/msn/564855.asp.
166 Gloria Feldt, Fetal Tissue Research Benefits Society, HR350 is Harassment, Not Law,
(November 9, 1999), at http://www.freerepublic.com/forun/a384ebd243304.htm.
167 See Dan Ferber, Ph.D., reviewed by Dr. Aman Shah, Stem-Cell Therapies Inch Their
Way Closer to the Clinic - But First Treatments Still Several Years Away (Aug. 18, 2000), at
http://my.webmd.com/content/article/1728.60509.
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fertilization clinics or from tissue from aborted fetuses. ' 6 8 Both Great
Britain's chief medical officer and Prime Minister recommended
"Parliament go one step farther and allow its scientists to actually clone
human embryos for medical research." 169 Consequently, the House of
Lords voted to allow "limited cloning of human embryos to produce
stem cells, in spite of vigorous objections from religious leaders,"'170
following the House of Commons approval the year before. 1
71
There were various vehement reactions to this decision. Some
opponents seemingly contend that it has "set the human race on the
path to a deeply troubling future: one where discarded human embryos
are used, like so many spare parts, to devise medical treatments using
their stem cells; or where embryos are created for the sole purpose of
being destroyed in order to develop stem cells that match a certain
person's genetic makeup."' 172 Yet, on the other side of the coin, some
supporters take the view that, "Now England can move ahead in this
competitive technology."' 173 But is America really moving ahead with
stem cell research with its stricter legislation in force? Regardless of
the answer, the NIH had to develop guidelines for scientists and
researchers to adhere to a set protocol and procedural standards.
NIH Guidelines
In order to establish rules helping to ensure that NIH-funded research
on pluripotent stem cells were "conducted in an ethical and legal
manner," 174 the NIH published guidelines in 2000 called the National
Institutes of Health Guidelines for Research Using Human Pluripotent
Stem Cells under the Clinton administration. These guidelines
instructed researchers on how to retrieve stem cells from discarded
human embryos and establish standards for harvesting similar cells
from fetal tissue following abortions. 175
168 Id
169 Gina Shaw, reviewed by Dr. Craid H. Kliger, Cloning: How Far Should We Go?.
(Sept. 29, 2000), at http://my.webmd.com/content/article/1691.50856.170 See Abortion Debate Clouds Future of Stem Cell Research, supra note 146.
171 Id.
172 Edmund Pellegrino, M.D., Cloning and Stem Cell Research: Too High a Price (Sept.
29, 2000), at http://my.webmd.com/content/article/1691.50914.
173 See Abortion Debate Clouds Future of Stem Cell Research, supra note 146.
174 National Institutes of Health Guidelines for Research Using Human Pluripotent Stem
Cells, (Effective Aug. 25, 2000, 65 FR 51976, Corrected Nov. 21, 2000, 65 FR 69951),
available at http://www.nih.gov.news/stemcell/stemcellguidelines.htm.
175 See Gertrude Murphy, M.D., Fetal Tissue and Embryo Research, (visited on May 25,
2001), at http://www.prolife-mclf.org/refjrnl/fetaltissue.htm.
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However, President George W. Bush's current policy would
replace these guidelines that never really went into effect. While the
old guidelines did not directly allow the use of federal subsidies to
destroy human embryos, they would have provided government
funding for research involving cells taken from embryos by privately
financed researchers, and would require that the embryos be "slated for
destruction at fertility clinics, frozen, and used in research with donors'
consent." 176 The replacement guidelines would have to be changed to
reflect President George W. Bush's stance on using only existing
colonies of stem cells from fertility clinics in future studies and barring
the use of federal grants on stem cells obtained from embryos after
August 9, 2001.
Interestingly, there had been no applications for stem cell grants,
even though the money was available. 177 However, the NIH did grant
Artecel funds for research into using fat tissue as a source of adult stem
cells for medical treatments.17 8 "The speculation was that researchers
were taking a wait-and-see attitude before committing to complex and
controversial experiments that could be canceled.", 7 9  John Gearhart,
Ph.D., a Professor of Obstetrics and Gynecology and a pioneering stem
cell researcher at The Johns Hopkins University in Baltimore, stated,
"'Concerned' is a fair statement. I think that there's been a great deal of
work and effort to position guidelines that are workable."
180
Additionally, Gearhart agreed that the technology should be overseen,
but noted, "Some of the most egregious potential abuses, like selling
embryos, are already outlawed." 18 1 Yet, Thomas Murray, chairman of
the NBAC's genetics advisory subcommittee, stated, "There is a
consensus forming that it is permissible to conduct this type of research
on embryos left over from [in vitro fertilization] procedures where they
would have been discarded in any event. ' 82 Essentially, the dilemma
becomes, "Do you thaw and throw them away, or use them as a source
of stem cells?"
'1 83
176 Goldstein et al., supra note 152.
177 See Abortion Debate Clouds Future of Stem Cell Research, supra note 146.
178 Durham's Artecel Wins Grant for Stem Cell Research, The Business Journal, July 24,
2001.
179 Abortion Debate Clouds Future of Stein Cell Research, supra note 146.
180 Id.181 id.
182 Tim Friend, Gov't Oks Fetal Tissue Research (May 23, 1999) at
http://www.lougehrigsdisease.net/alsnews/990524govt-oks fetaltissue_research.htm..
183 id.
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There were no grants for fetal stem cells until late May of 2002,
when the U.S. government quietly approved the first federally funded
project using stem cells from fetuses aborted up to eight weeks after
conception. 184 This was possible since President George W. Bush's
restriction only applied to an embryo and not to a fetus, subjecting the
stem cells taken from fetuses to different, broader rules. 85 According
to NIH officials, stem cell taken from a fetus fall under the "less-
restrictive Clinton-era rules"' 86 since Bush never revised the guidelines.
White House officials said that Bush did not modify the guidelines for
fetal-derived cells because of the 1993 law that made it illegal for a
president to ban funding on stem cell research. 187 As a result of not
amending these rules, "days-old embryos have some protections that
eight week old fetuses don't."' 88  Essentially, this grant not only
expanded the reach of federal funding of stem cell projects, it fueled the
fire of the ethical debate surrounding this research.
While the guidelines will not allow embryos to be created through
the practice of cloning, nor will they allow the use of embryos outside
of the sanctioned 60 lines, opponents still argue that embryos are being
destroyed to benefit another human being.' 89  Edmund Pellegrino,
M.D., a John Carroll Professor of Medicine and Medical Ethics at The
Center for Clinical Bioethics at Georgetown University Medical
Center, contends, "...no matter what the medical benefits of this
research, you cannot kill one member of the human species so that
good may come to another."' 190 In reference to the stem cells benefiting
others, Gregory Pence countered by stating:
"...the NIH's decision to permit federally funded research
using stem cells from human embryos, and the even farther-
reaching recommendation by the British to permit cloning of
embryos for research purposes, are so important ... if human
cloning and related technologies are allowed to proceed ...
conditions like Alzheimer's, Parkinson's, diabetes, heart
184 See Jeremy Manier, U.S. Quietly OKs Fetal Stem Cell Work Bush Allows Funding
Despite Federal Limits On Embryo Use, Cm. TRIB., July 7, 2002, § I at 1.
185 See Manier, supra note 184.
186 id.
187 Id.
188 id.
89 See Pellegrino, supra note 172.
90 Id.
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failure, degenerative joint disease, and other problems may be
made not just treatable, but curable...' ' g
Laws that Protect Women and Govern Fetal Tissue Donation
In addition to many state laws that apply to the transplantation and
research of fetal tissue, there are two principal federal laws, NOTA and
the NIH Revitalization Act of 1993, which govern within this arena as
well.192 NOTA, or The National Organ Transplant Act provides for
grants of organs and tissues in order to conduct research or be used for
transplantation, (amended to include fetal organs and tissues) and The
National Institutes of Health Revitalization Act of 1993 allows federal
funding for fetal tissue research on transplantation for therapeutic
purposes.
93
More specifically, the Revitalization Act allows the fetal tissue
specimen to be obtained from either a spontaneous or induced abortion,
or a stillbirth, and requires the mother to give written consent to the
abortion before discussing the possibility of donating the tissue. 194 It
also requires that she be informed through a written and signed
statement, i.e., informed consent document, by her physician disclosing
any possible interest that the physician may have in the fetal tissue
research. 195 Furthermore, the Revitalization Act prohibits "the mother
from knowing or restricting the identity of the recipient, and a
researcher from taking part in any decision that would affect the timing,
method, or procedure used to end a pregnancy made solely for the
purposes of research."' 96 Additionally, under the NIH Guidelines for
Research Involving Human Pluripotent Stem Cells, the donor cannot be
monetarily or otherwise induced for donations, and specific written
policies and practices should be implemented to safeguard against any
such inducements. 197 It is important to note that "penalties for violating
this law include a fine - in an amount not less than twice the amount of
19' See Gregory Pence, Ph.D., The Lifesaving Promise of Cloning Technology (Sept. 29,
2000) at http://my.webmd.com/content/article/1691.50913.
192 See Donating Fetal Tissue for Medical Treatment and Research, supra note 15, citing
42 U.S.C.A. § 274e (1988); 42 U.S.C.A. § 289(g)(1) (1993).
193 Id.
194 Id.
195 ld. See also National Institutes of Health Revitalization Act of 1993, 42 U.S.C. § 289
(2002).
196 See Donating Fetal Tissue for Medical Treatment and Research, , supra note 15,
citing42 U.S.C.A. § 274(e) (1988); 42 U.S.C.A. § 289(g)(1) (1993).
197 National Institutes of Health, Guidelines for Research Involving Human Pluripotent
Stem Cells, (Aug. 25, 2000, amended Nov. 21, 2000).
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the valuable consideration - or up to 10 years in prison, or both." '198
Lastly, additional non-compliance with the terms of the NIH
Guidelines may result in the imposition of special conditions on federal
grants, increased oversight, monitoring, reporting requirements,
withholding of funds, disallowance of all or part of the project costs, or
suspension or termination of all or part of the grant. 
199
Some opponents to this research try to bolster their position by
contending the companies that place their employees in facilities for the
purpose of retrieving the delicate specimens are, in their view, fetal
tissue wholesalers.200 While both NOTA and the NIH Revitalization
Act permit reasonable payments, i.e., one that complies with 42 U.S.C.
289g-1 for the "removal, transportation, implantation, processing,
preservation, quality control, and storage of the tissue, ' '2° 1 they each
prohibit the sale of human organs and tissues for research or
transplantation.20 2 Thus, both Acts, as well as federal law, disallow the
sale of fetal tissue, and not the collection of specimens in order to
ensure their viability and prompt distribution. Hence, these companies
cannot be considered sellers in any legal sense of the term.
Distributive Sources of Fetal Tissue
In the United States, three primary sources of fetal tissue, i.e., hospitals,
abortion clinics and obstetrical/gynecological physicians, obtain written
consent and then send the fetal tissue to researchers associated with
academic institutions, commercial companies, and other non-American
institutions.2 °3  Because of the tissue's fragile nature, it must be
"immediately transported by researchers to their laboratories or some
198 See Donating Fetal Tissue for Medical Treatment and Research, , supra note 15,
citing 42 U.S.C.A. § 274(e) (1988); 42 U.S.C.A. § 289(g)(1) (1993). See also National
Institutes of Health Revitalization Act of 1993, Title I - General Provisions Regarding Title IV
of Public Health Service Act, Subtitle A - Research Freedom, Public Law 103-43; June 10,
1993; 42 U.S.C. 289, Section 498A, Research on Transplantation of Fetal Tissue.
'99 National Institutes of Health, Guidelines for Research Involving Iuman Pluripotent
Stem Cells, (Aug. 25, 2000, amended Nov. 21, 2000).
200 See Paul Likoudis, At Home in the Culture of Death... Dead Baby Parts Business
Booming, (Oct. 14, 1999) at http://www.freerepublic.com/formula/a37f3c9b33 I al.htm.
201 See Donating Fetal Tissue for Medical Treatment and Research, supra note 15, citing
42 U.S.C.A. § 274(e) (1988), and 42 U.S.C.A. § 289(g)(1) (1993).
202 id.
203 See Donating Fetal Tissue for Medical Treatment and Research, supra note 15, citing
Vawter et al., The Use of Human Fetal Tissue: Scientific, Ethical, and Policy Concerns, UNIV.
OF MINN., CTR. FOR BIOMEDICAL ETHICS (1990).
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other location where it can be safely stored and kept from
deteriorating."
20 4
"While solid organs are obtained and distributed through
the national Organ Procurement and Transplantation
Network, there is no formal, organized, national network
for procuring and distributing fetal tissue. Instead, several
nonprofit organizations -- including the National Disease
Research Interchange, the Mid-America Transplant
Association, the International Institute for the
Advancement of Medicine, and the American Association
of Tissue Banks -- are involved in obtaining and
distributing fetal tissue. These organizations are generally
responsible for examining and evaluating the tissue,
providing storage facilities, and distributing tissue to the
biomedical community. Some of these organizations
interact directly with private laboratories or pharmaceutical
companies that perform medical research with fetal tissue.
In these cases, they are usually compensated for the efforts
and costs associated with the transportation, storage, and
evaluation of the tissue. 20 5
Most recently, the Central Laboratory for Human Embryology at the
University of Washington (which is supported by the Ni) supplies
tissue from "normal or abnormal embryos and fetuses of desired
gestational ages between 40 days and term."
206
Opposition to Using Donated Fetal Tissue for Medical Research
Opponents of fetal tissue research usually consist of religious, pro-life
and anti-abortionist groups, and other individuals or organizations with
similar views. The arguments vary, ranging from fetal tissue research
being a conspiracy with the abortion industry for donor benefit or
financial gain, to the research being accused of taking a human life,
even though it is being used to potentially save lives.
204 See Donating Fetal Tissue for Medical Treatment and Research, supra note 15, citing
Dorothy E. Vawter, PERSONAL COMMUNICATION (1999).
205 See Donating Fetal Tissue for Medical Treatment and Research, supra note 15, citing
Maryon F. King, et al., Touchy Subjects: Marketing a Controversial Product Such as Fetal
Tissue Research Requires Sensitivity and Finesse, J. HEALTH CARE MARKETNG 16 (1995); 42
U.S.C.A § 274(e) (1988).
206 See Likoudis, supra note 200.
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"Some religious groups say using fetal tissue from aborted fetuses
amounts to collaboration with the abortion industry." 20 7 Challengers
argue that cooperation in future abortions occurs if the use of tissue
influences a woman's decision to conceive for the sole purpose of
donating the aborted tissue, especially to a family member, which will
in turn increase the rate of elective abortions. 20 8  They feel these
women may be influenced to abort since some 'good' may come from
the use of cadaveric fetal tissue for therapy, thereby legitimizing FTT
and the abortion industry. 209
Summarily, the opposition believes:
"Fetal tissue research cannot justify abortion by citing a
benefit from it. The fact still remains that unborn babies
are being killed and now what's left of their little bodies are
being used in experiments in an attempt to preserve the
lives of others. These babies don't get a say in either
matter."
210
Additionally, some non-advocates contend that abortions will
increase as the supply and demand for fetal tissue is realized and
necessary for further research. 211  Brian Clowes, author of the
American Life League's Pro-Life Activist's Encyclopedia entry on
fetal experimentation: Frankenstein Revisited, estimated that there
would be an increase for organ and tissue harvested from aborted
fetuses in order to meet the demand from aging and callous American
baby-boomers. He predicted that the following would result: "Inflated
prices.. ., a thriving black market; the growing and selling of pre-born
babies for sale; the import of fetal tissue from poor and developing
countries; and entrepreneurs encouraging women to abort as late as
possible for a monetary reward,, 212 and wrote the following excerpt in
ALL's Encyclopedia in 1995:
207 See Don Colburn, The Fetus: Medicine, Law and Morality, WASH. POST
HEALTH, Oct. 18, 1988, at 17.
208 See Patricia Schrock, Fetal Tissue Transplantation (Winter 1997), at
http://www.hsc.missouri.edu/-shrp/ radsci/fetal/fetal I .html.
209 Gertrude Murphy, M.D., Fetal Tissue and Embryo Research (May 25, 2001), at
http://www.prolife-mclf.org/refjml/fetaltissue.htm. See also Patricia Schrock, Fetal Tissue
Transplantation (Winter 1997), at http://www.hsc.missouri.edu/-shrp/ radsci/fetal/fetal I .html.
210 Professor Bill Dalton, The News On Fetal Tissue Research, at
http://shrike.depaul.edu/-dmiler3/fetal.html (last visited on Jan. 13, 2003).
211 See Murphy, supra note 209.
212 See Likoudis, supra note 200.
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"It may be expected, that as many as five million people
will make use of fetal tissue on a regular basis. This means
that the total amount of fetal tissue required to satisfy the
demands of these 'neo-vampires' will be measured in the
tons every year. Since there are only about 120,000 second
and third trimester abortions in the United States, this
means that demand for fetal tissue will crushingly and
inevitably overwhelm the available supply.
213
These opponents sarcastically describe the research "in cold,
clinical research terms, [as] the end product of the 'fetal tissue issue' -
an economically important byproduct of the sexual revolution."
214
While they feel that this "marketability of fetal tissue may also
encourage indirect ways of increasing the abortion rate, ' 215 they also
argue that there is some type of financial gain for "baby parts
trafficking." 21 6 This trafficking is depicted by contentions of financial
incentives to the woman, abortion clinics and researchers, often
pointing out the possibility of a potential conflict of interests.
217
"Subsequently, the House of Representatives passed a resolution
calling for congressional hearings to investigate so-called 'trafficking
in baby body parts for profit."'
218
Much of the trafficking argument encompasses the way the tissue
samples are collected and distributed to the research facilities. For the
most part, these non-advocates contend:
"Fetal tissue research exploits women by altering abortion
techniques, because doctors need good tissue samples to
use. When women consent to donate their fetuses to
research, doctors modify the suction procedure, so it won't
be hard to identify various tissues and so they will be able
213 id.
214 Id.
215 See Patricia Schrock, Fetal Tissue Transplantation (Winter 1997), at
http://www.hsc.missouri.edu/-shrp/ radsci/fetal/fetal .html.
216 See Murphy, supra note 209.
217 See Schrock, supra note 215.
211 See Donating Fetal Tissue for Medical Treatment and Research, citing H.R 350,
106th Cong., (Ist Sess. 1999). Expressing the Sense of the House of Representatives with
Respect to Private Companies Involved in the Trafficking of Baby Body Parts for Profit.
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to retrieve intact fetuses. 'The role of women in fetal
tissue research is, after all, to provide the raw material."'
219
Furthermore, they bolster their argument by contending that "some pre-
born babies are not dead when brain tissue is extracted because of the
desirability to use only fresh living cells for some transplants," 220 and
that "the necessity to obtain fresh tissue requires close cooperation
between the abortionist and the research team because methods of
collection are important because orders go out for certain age and type
of tissue, etc."
221
Subsequently, "the anti-choice organization, Life Dynamics
Incorporated accused abortion providers of performing abortions to
,222profit from the sale of [fetal parts]," and in 1999, supposedly
"uncovered documented evidence of baby body parts trafficking. '" 223
The organization alleged that after a two-year under cover
investigation, it obtained documented evidence that Opening Lines, a
company in West Frankfort, Illinois "was procuring and selling fresh
baby parts to fetal tissue researchers around the country." 224  In
addition to printing that "one could buy a whole specimen (aborted
baby) in 'un-processed condition' for seventy dollars," 225 it also gave a
price list for the various body parts including livers for $125-$150,
spleens for $50-$75, pancreases for $75-$100, thymus for $75-$100,
kidneys for $100-$125, limbs for $150, brains for $150-$999, spinal
columns for $150, and spinal chords for $325.226
Furthermore, Life Dynamics chastised Opening Lines'
promotional brochures for abortion clinics and researchers in the
industry, which acknowledged the difficulty of the patient's decision
and the chance to propose to the patient "a simple program that could
help thousands of people. ,227 Moreover, the literature denoted, "This is
219 See Dalton, supra note 210.
220 See Murphy, supra note 209., citing Bernard Nathanson, Fetal Tissue Research and
Experimentation, ALL ABOUT ISSUES (Mar-Apr 1992).
221 See Murphy, supra note 209.
222 See Planned Parenthood Federation of America, Inc., Donating Fetal Tissue for
Medical Treatment and Research (Feb. 2000), at http://www.plannedparenthood.org/library/
facts/fetaltis 01 0600.html.
223 Explosive News! Baby Body Parts For Sale, at http://www.thekingsnetwork.com/
stopftr/partsforsale.html, (last visited May 25, 2001).
224 id.
225 ld.
226 id.
227 See Likoudis, supra note 200.
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an opportunity to make a difference ... and it can be beneficial to your
cliniC,228 when referring to the leasing of space, offsetting a clinic's
overhead, reimbursing employees' salaries and training competent
personnel for this highly delicate procedure. 229 Life Dynamics also
makes light of the company's reassurances that its specimens are high
in quality, shipped promptly, affordable, and delivered in the specified
quantities.
230
Allegedly, an organ harvester, "Kelly," who supplied Life
Dynamics with the controversial documents, stated:
"Women are "coerced" into having abortions [and] would
change their minds after entering the abortion mills, but
they were sedated by staff into a 'Nyquil nap'. Women are
encouraged to have late-term abortions to meet the
demands of an industry that requires intact specimens and
tissues."23'
Consequently, Mark Crutcher, president of Life Dynamics at the time,
added to this claim by saying, "This is about maximizing profits. First,
you sell the woman an abortion. Then you turn around and sell the dead
baby you take out of her. But you have to take it out whole or you
don't have anything to sell."232
Many of these opponents, (some medical experts, along with
Catholic activists and anti-abortion lawmakers) are concerned with the
actual physical destruction of embryos, and "note that getting the stem
cells requires destroying the embryos in which they grow, saying that
'it trades away life in the name of science,' ' 233 and most do not
subscribe to the idea of cloning for analogous reasons. Similarly,
Edmund Pellegrino opposes the idea of cloning and argues that:
"Beginning with basic medical ethics, the creation of
human embryos for medical research is a violation of the
very first principle of bioethics: We cannot use a human
merely as a means to an end. Each person -- even an
228 Id.
229 id.
230 Id.
231 Id.
232 See Likoudis, supra note 200.
233 Sean Martin, reviewed by Dr. Michael W. Smith, Stem Cell Controversy Draws
Celebs to Capitol Hill (Sept. 14, 2000) at http://my.webmd.com/printing/articie/ 1728.61328.
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embryonic person of only a week's gestation -- is an end in
him- or herself. But this research will require the
destruction of the embryo. We would be creating life so
that it may be killed. 2
34
These opponents argue that life has already begun at the
embryonic stage and that the fetus has rights. They feel that fetal
research is "the denial of the personhood of unborn children, while
acknowledging that their tissue is useful because it is human, [and] in
short, says to the unborn, 'You can be useful to society, you just can't
be a member of it."' 235  Moreover, a Kansas City pastor, Russell
Saltzman, rhetorically asked:
"Does good ever derive from evil means? Is the human
embryo human life, or is it a mere bit of research material?
If it is mere research material, why should any human life
at any stage of development -- yours or mine -- carry any
special privilege? 2 36
The view is that, "Tissues from a deceased human fetus are entitled to
the same respect and dignity as from a deceased adult or child, no
more, no less.
237
But even when it comes to the suffering of others with debilitating
or incurable diseases, these non-advocates still find fetal tissue research
undesirable. There are some who argue that not only is it an
abominable practice and morally wrong, but it is unessential by
advocating the use of "fetal cells from non-human fetuses or other
biotechnology derived nerve cells [that] can likely be developed as safe
and effective alternative cell sources for transplantation to patients with
neurodegenerative diseases. 238 Not surprisingly, Pellegrino addressed
this issue as well, and was quoted as stating:
234 See Pellegrino, supra note 172..
235 See Gertrude Murphy, M.D., Fetal Tissue and Embryo Research (May 25, 2001), at
http://www.prolife-mclf.org/refjrnl/fetaltissue.htm. See also Patricia Schrock, Fetal Tissue
Transplantation (Winter 1997), at http://www.hsc.missouri.edu/-shrp/ radsci/fetal/fetal l.html.
236 See Martin, jupra note 233.
237 See Patricia Schrock, Fetal Tissue Transplantation (Winter 1997), at
http://www.hsc.missouri.edu/-shrp/ radsci/fetal/fetall.html, citing Henry Greely et al., Special
Report: The Ethical Use of Human Fetal Tissue in Medicine, N. ENG. J. MED 1094 (1989).
238 See Ole Isacson, M.D., Ph.D., On the Brain: Fetal Nerve Cell Transplantation:
Advances in the Treatment of Parkinson's Disease, (The Harvard Mahoney Neuroscience
Institute Letter) (1994), available at http://neurosurgery.mgh.harvard.edu/oisacson.htm.
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"Still, you may say, what about people with Parkinson's or
Alzheimer's? What about people who need organ
transplants? Doesn't the extremity of their medical need
justify such extreme steps if it can help them? In my view,
the answer is no, since we must kill the embryo to obtain
the cells in the first place. But even if one could justify
this kind of research on moral and ethical grounds, creating
human embryos -- or even using discarded ones -- is
simply not necessary in order to obtain the needed stem
cells.s
239
Furthermore, there are non-advocates that oppose the use of
vaccines created from fetal cell lines because it involves taking cells
from an aborted baby and growing them for many generations in a
laboratory. 240  Therefore, they are against the inoculation of the
following vaccines: MMR II (Rubella component),
Measles/Mumps/Rubella (Priorix), Rubella (Ervevax), Rabies (HDCV)
(Imovax), Hepatitis A (Havarix) and (Avaxim), Polio, and Chickenpox.
These vaccinations are licensed by the FDA and commonly used in the
United States. 241  The opponents claim to have found alternative
vaccines derived from monkeys, chickens, and rabbits.242 However,
some countries supplying the alternative vaccines are trying to limit
their liability, placing the integrity of the vaccinations in question. For
example, the Kitasato Institute in Japan agreed to supply their rubella
vaccine made from an animal cell line, but "have made it clear that no
compensation is available outside Japan for any side effects as a result
of the vaccine in line with Japanese law." 243 Moreover, the source
supplying the alternative vaccine information warned of potential side
effects, stipulated that the vaccine is for the sole use of the named
patient (cannot be transferred to a third party), and specified that the
patient's doctor must sign a paper accepting full liability for
239 See Pellegrino, supra note 172.
240 Catherine Williams, The Campaign for Ethical Vaccines: Alternatives to Vaccines
Made from Aborted Babies, (May 25, 2001), at http://www.dgsoft.co.uk/homepages/
vaccines/alternatives.htm.
241 Id.
242 Id.
243 Id.
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administering the vaccine, which also bars the physician from bringing
suit against the supplier.
244
Even some major organizations, such as The American Heart
Association, do not support or fund scientific research that involves
human fetal tissue. It made this decision after "careful and extensive
examination of information from affiliates, councils and volunteers, as
well as from scientists, ethicists, community leaders and church
representatives, 2 45 and declared that their research program funded no
grants using this type of fetal tissue.246 However, the AHA noted that it
will, "continue to fund meritorious biomedical research that's consistent
with our mission to reduce disability and death from cardiovascular
diseases and stroke."
247
However, there are some opponents, as well as proponents, to fetal
tissue research who have views inconsistent with other stances
comprising their belief systems. For example, Tommy Thompson, the
Secretary of Health and Human Services, opposes abortion but he will
supervise the federal research establishment. 24 8 He even commended
both a University of Wisconsin scientist for the work he completed on
stem cells and James Thomson, Ph.D., for innovative findings in stem
cell research. And surprisingly, there are people who are pro-
abortion, yet anti-stem cell research. One feminist pro-abortion group
advocates that abortion methods "may be changed or delayed in order
to obtain the best tissue," which puts the woman more at risk, and in
turn, exploits women.25 °
Divided Ethicists View
Even ethicists disagree on a universal stance regarding "whether it is
appropriate to create new cells from very early human embryos' 251 and
244 Id.
245 Fetal Tissue Research, (May 25, 2001), at http://www.americanheart.org/
Heart and StrokeA ZGuide/fetaltissue.html.
246 Id.
247 id.
248 See Abortion Debate Clouds Future of Stem Cell Research, supra note 146.
249 id.
250 Gertrude Murphy, M.D., Fetal Tissue and Embryo Research, (May 25, 2001), at
http://www.prolife-mclf.org/refjrnl/fetaltissue.htm, citing Janice Raymond, Professor Women's
Studies, U. MASS. & MIT, testimony subcommittee on Health, Apr. 1991.
251 See Dan Ferber, Ph.D., Ethicists Divided Over Human Embryo Research - Existing
Cells OK to Use, but Don't Make New Ones, Some Say (Feb. 22, 2000), at
http://my.webmd.com/content/article/1 78.55182.
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"whether the government should fund this type of research. ' 52 While
representatives of some bioethics committees believe it is morally
acceptable to use existing cultured human embryo cells for research
purposes, others find it unacceptable to "destroy a living human
embryo, even one with just a handful of cells, in order to create new
,,253
cells. '  Notably, embryonic stem cells are categorized into two
groups by both ethicists and scientists: (1) stem cells derived from
embryos fertilized in a test tube, and (2) those obtained from electively
aborted fetuses. 54 The Director of the Ethics Institute at Dartmouth
College, Ronald Green, Ph.D., said, "[F]or most ethicists, this is not a
particularly troubling question... [t]hat's because such [existing stem]
cells lack the ability to produce a living human embryo."' z  Yet, a
panel of ethicists assembled at the annual meeting for the American
Association for the Advancement of Science (AAAS) discussed the
issue and "recommended that researchers be able to use existing cells,
,,256but declined to recommend the creation of new ones.. However,
Thomas Murray, Ph.D., President of the Hastings Center and National
Bioethics Advisory Commission (NBAC), stated that a panel of
prominent NBAC ethicists concluded that research using the creation of
new stem cells was acceptable under certain conditions.
257
Support for Using Donated Fetal Tissue for Medical Research
Despite some propagandized allegations and the unclear stance of the
bloethicist community, there is staunch support for fetal tissue research
and its appropriate medical use. Since approximately 1.6 million legal
abortions are performed in the U.S. each year," 58 proponents generally
advocate the use of electively aborted fetuses rather than discarding
them. They feel that the wastage of fetal tissue from these abortions is
a travesty as it is "too valuable not to use in a research or therapeutic
setting because of the large number of persons suffering from various
252 id.
253 ld,.
254 Id,
255 id.
256 Id.
257 id
258 See Patricia Schrock, Fetal Tissue Transplantation (Winter 1997), at
http://www.hsc.missouri.edu/-shrp/ radsci/fetal/fetall.html, citing Robert Hurd, Ethical Issues
Surrounding the Transplantation of Human Fetal Tissue, CLINICAL RESEARCH 661 (1992).
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neurodegenerative conditions" 259 that can benefit from it or potentially
be cured.260 Some advocates feel we should "look to history to provide
examples of moral uses of results that are obtained under questionable
circumstances. 261
"For example, although many consider the American
bombing of Nagasaki immoral, no one questions the
morality of using the radiation exposure information
obtained to benefit future victims. At least some good can
be obtained from this bad situation. So even if one were
morally opposed to abortion, fetal tissues could be used in
medical research and transplantation in hopes of gaining
positive results for society.
262
Furthermore, proponents disagree with the contention that the
salvaging and use of fetal tissue is being conducted to legitimize
abortion, and that it will encourage more abortions. While opponents
contend that this research will make it "less morally offensive and more
easily tolerable both to the pregnant woman and society in general,"
advocates argue that these allegations are highly speculative and that
the "primary motivation for elective abortion is the desire to avoid an
unwanted pregnancy;' ' 263 not to benefit a potential fetal tissue donee.
One might facetiously analogize the use of fetal tissue donation to the
use of organs of homicide, suicide, and accident victims for
transplantation purposes by stating that we should not have organ
donation because:
The willingness to use the organs might be seen to
encourage or legitimate such deaths, or at least make it
harder to lower speed limits, seatbelt, gun control, and
drunk driving laws to prevent them. After all, the need to
259 See Schrock, supra note 258, citing Dennis Turner and Warren Kearney, "Scientific
and Ethical Concerns in Neural Fetal Tissue Transplantation," Neurosurger , Dec. 1993, p.
1034.
260 id.
261 See Patricia Schrock, Fetal Tissue Transplantation (Winter 1997), at
http://www.hsc.missouri.edu/-shrp/ radsci/fetal/fetall.ihtml, citing Mary B. Mahowald et al.,
The Ethical Options in Transplanting Fetal Tissue, HASTINGS CTR. REP. 14 (1987).
262 See Patricia Schrock, Fetal Tissue Transplantation (Winter 1997), at
http://www.hsc.missouri.edu/-shrp/radsci/fetal/fetal 1 .html.
263 See Patricia Schrock, Fetal Tissue Transplantation (Winter 1997), at
http://www.hsc.missouri.edu/-shrp/ radsci/fetal/fetall.htnl, citing John A. Robertson, Rights,
Symbolism, and Public Policy in Fetal Tissue transplants, HASTINGS CTR. REP. 7 (1988).
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prevent murder, suicide, and fatal accidents becomes less
pressing if some good to others might come from use of a
victim's organs for transplant. In either case, the
connection is too tenuous and speculative to ban organ or
264fetal tissue transplants.
Others have paralleled this unfounded fear of choosing abortion in
order to donate fetal tissue, as the "absurd suggestion "that a wife
would withdraw life support from her dying husband in order to enjoy
the satisfaction of donating his kidney. ' '265 Ethicist Dorothy Vawter
stated, "The option to donate fetal tissue is at least equally irrelevant to
a woman's decision to abort as the option to donate a hip bone is to a
patient considering a hip replacement. ' '266 In the most simplest terms,
"A woman's choice to donate to medical research [a fetus] she has
aborted begins and ends with her.",267  Some advocates believe "the
choice to donate [fetal tissue] often gives solace to [those] who may
need to end their pregnancies, ' 268 thus aiding in the emotional and
mental recovery a woman may require after having an abortion.
But the truth is, "there is no evidence that the option to donate
tissue to an anonymous recipient encourages a woman to terminate a
pregnancy she would otherwise carry to term., 269  Additionally, "in
1993 the National Institute of Health Advisory Panel 'could find no
evidence that legitimization or redemption would sway the complex
and highly personal choice leading to an abortion procedure toward
either an increased moral comfort with the decision on the part of the
individual woman, or more abortions being performed overall."' 270
Actually, "there is evidence of strong support for research using fetal
tissue... among women in general."
"In a survey of more than 600 women in the United
Kingdom - most of whom had never had an abortion
264 id.
265 See Donating Fetal Tissue for Medical Treatment and Research, supra note 222.
266 Id.
267 Id.
269 See Donating Fetal Tissue for Medical Treatment and Research, supra note 222,
citing Anderson, Fionn, et al., Attitudes of Women to Fetal Tissue Research, 20 J. MED. ETHICS
36-40 (1994).
269 Donating Fetal Tissuefor Medical Treatment and Research, supra note 222.
270 See Patricia Schrock, Fetal Tissue Transplantation (Winter 1997), at
http://www.hsc.missouri.edu/-shrp/radsci/fetal/fetal .html.
271 See Donating Fetal Tissuefor Medical Treatment and Research, supra note 222.
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94 percent said they supported fetal tissue research.
Although the women were not asked in the survey to
donate their own fetus, most predicted that they would be
willing to make such a donation., 7
2
Foremost, proponents argue that fetal tissue research should not be
equated as an 'immoral' act, thus "associates all the users with the
initial immoral act." 273 Frequently used as a counter-argument to this
assertion is the following comparison involving organ transplantation
from a homicide victim:
"Families of homicide victims are often asked to donate the
organs/body for education, research, or therapy purposes.
Upon consent, tissue procurement agencies retrieve and
distribute the organ/body to recipients. The anatomy student
studying the cadaver, the surgeon who transplants the
victim's kidneys or heart, and the transplant recipient are not
accomplices to the homicide. While they are beneficiaries of
the homicide, they played no role in causing the
homicide..."274
Essentially, one may benefit from another's act without having a part in
or approving of the act.
275
In defense of fetal tissue collection and distribution, proponents
justify the necessity for the specimens to be of the utmost quality,
shipped expediently and to comprise the exact specifications of the
requesting scientists in order to produce successful and valid research
results. These advocates explain that when tissue requests stipulate,
"no anomalies" or "no congenital abnormalities", it is not evidence of
"perfectly healthy babies being aborted for organ harvesting," 276
instead, it is prevention against the use of abnormal tissue that may not
be conducive for research purposes, or may produce fallacious results.
In other words, "fetal tissue obtained through induced abortion--
excluding those with fetal defects -- are highly suitable for research and
272 Id.
2713 See Patricia Schrock, Fetal Tissue Transplantation (Winter 1997), at
http://www.hsc.missouri.edu/-shrp/ radsci/fetal/fetall.html, citing John A. Robertson, Rights,
Symbolism, and Public Policy in Fetal Tissue transplants, HASTINGS CTR. REP. 1026 (1988).
274 Id.
275 id.
276 See Likoudis, supra note 200.
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therapy because they are likely to be free of major genetic
abnormalities and viral, fungal, or bacterial infections,277 and are more
apt to warrant the most authentic results.
Nonetheless, many proponents of fetal tissue research and
transplantation encompass various professional communities. Some
scientists that support the practice say, "it's important not to close off
the possible roads to cures that the embryo cells may offer." 278
President and CEO of Geron Corporation in 2000, Thomas Okarma,
acknowledged, "we are powerless to urge a diseased or damaged organ
to repair itself ...That's the excitement, and that's the potential of this
technology., 279 Similarly, several advocate doctors are very vocal on
the issue. In fact, "Swedish neurologist Lars Olson says some research
has gotten to the point where he feels it would be ethically
unacceptable not to try the procedures." 280 However, those outside of
these professional circles observed "doctors, as well as the legal system
in this country, have not yet decided how to deal with the concept of
fetal rights.28'
While that perception may be true, it does not dissuade advocates
to support the research, even including some celebrities suffering with
incurable diseases. "Actors Mary Tyler Moore and Michael J. Fox
testified before Congress to urge federal funding for this type of
research.",282  Moore, who has had diabetes for over 30 years and
represents the Juvenile Diabetes Foundation, said real life people
suffering from diseases should get priority over embryos. Fox, who
suffers from Parkinson's, urged lawmakers to allow stem cell research
to commence. 283  Even former President Ronald Reagan, who has
Alzheimer's disease, (and opposed fetal tissue research) can be added to
the list of celebrities that could benefit from further research, hopefully
leading to "cure or even a treatment that's effective in the long term." 284
Fortunately, some organizations, such as Planned Parenthood
Federation of America, recognize the "important role ... fetal tissue
277 See Donating Fetal Tissuefor Medical Treatment and Research, supra note 222.
278 See Martin, supra note 233.
279 See Dan Ferber, Ph.D., Ethicists Divided Over Human Embryo Research - Existing
Cells OK to Use, but Don't Make New Ones, Some Say (Feb. 22, 2000), at
http://my.webmd.com/content/article/1 78.55182.
280 See Colburn, supra note 207.
281 Id.
212 See Martin, supra note 233.
283 Id.
284 See Pence, supra note 191.
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can play in potentially lifesaving medical research., 285  Its policy is
that:
"The decision to donate-- like every other sexual and
reproductive health decision-- belongs to each individual
woman, and it is not ours to make. Our job is to offer a
woman the information and support she needs to make her
own informed decision, according to her own personal
circumstances and the dictates of her conscience. It is
always her choice.2 86
Additionally, representatives from the organization admonished that:
"Planned Parenthood deplores the on-going attempts by
extreme anti-choice politicians to curtail scientific research
and medical advances for the sake of hyperbole and to
demonize women who seek to control their own fertility.
We support individuals' rights to consent to organ, cadaver,
or fetal tissue donations for the purpose of medical
research in the pursuit of saving lives and treating and
curing diseases."
287
Furthermore, Dan Perry and a number of other patient advocacy
groups announced the formation of The Patients' Coalition for Urgent
Research, (CURe) a group that backs federal funding of stem cell
28research using donated embryos and fetal tissue. 88 In addition to the
AAR, coalition members include the following organizations:
American Cancer Society, Glaucoma Research Council, Juvenile
Diabetes Foundation International, Parkinson's Action Network,
Resolve: The National Infertility Association, and the Spina Bifida
Association, Inc., 2 8 9 as well as the Christopher Reeve Paralysis
Foundation and others that are fighting glaucoma and Huntington's
290Disease.
Notably, Perry released an opinion poll that suggested three out of
four Americans supported federally funded research that involves
285 See Donating Fetal Tissue for Medical Treatment and Research, supra note 222.
286 Id.
287 See Gloria Feldt, Fetal Tissue Research Benefits Society, HR350 is Harassment, Not
Law, (November 9, 1999), at http://www.freerepublic.corn/forum/a384ebd243304.htm.
288 See Friend, supra note 182.
289 See Likoudis, supra note 200.
290 See Friend, supra note 182.
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291extracting cells from embryonic sources. Subsequently, CURe
started lobbying in Washington, D.C. for federal taxpayer funding of
stem cell research involving the use of human embryos, accompanied
by evidence showing the benefits of fetal tissue research for many
diseases.
292
Alternatives to Fetal Tissue
Generally, most opponents advocate specimen sources that are free of
ethical and moral dilemmas, and mainly use the counter argument that
the tissue needed for research can be obtained from adult humans, such
293 294as bone marrow,293 and from the stem cells of dead people.
However, some of these specimens may take the form of ectopic
pregnancies, stillbirths, and spontaneous abortions, 2 95 and not all of
these opponents agree with their use for experimentation purposes.
Researchers have turned human bone marrow stem cells into nerve
cells, 296 and studies showed that adult cells presented more options than
previously thought by the scientific community. 29  Astonishingly,
"some kinds of stem cells already have been an accepted medical
treatment for years." 298 Ira Black, M.D., and professor of neuroscience
and cell biology at the Robert Wood Johnson Medical School in
Piscataway, N.J. stated:
"Physicians transplant bone marrow because it contains
stem cells that can form blood cells to replenish depleted
blood in patients with cancer and other diseases. Although
researchers had known that bone marrow contained stem
cells, until recently they thought that other adult cells could
not alter their destinies ... These cells are far more flexible
than anyone suspected just a few short years ago.
291 id.
292 See Likoudis, supra note 200..
293 See Dan Ferber, Ph.D., Ethicists Divided Over Human Embryo Research - Existing
Cells OK to Use, but Don't Make New Ones, Some Say (Feb. 22, 2000), at
http://my.webmd.com/content/article/1 78.55182.
294 See Martin, supra note 233.
295 See Donating Fetal Tissue for Medical Treatment and Research, supra note 222.
296 See Dan Ferber, Ph.D., reviewed by Dr. Aman Shah, Stem-Cell Therapies Inch Their
Way Closer to the Clinic - But First Treatments Still Several Years Away (Aug. 18, 2000), at
http://my.webmd.com/content/article/ 1728.60509.
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Furthermore, some scientists claim that adult bone marrow stem
cells may have the same potential as fetal stem cells, 300 and the same
great promise in treating diseases like muscular dystrophy, Parkinson's,
and Alzheimer's.
30 1
"Studies conducted in England and the United States and
published in a range of leading journals including Science,
Nature, and Hepatology found that stem cells can be
obtained from adult humans, using sources such as bone
marrow cells. These cells would still have the all-important
pluripotentiality of stem cells -- the ability to develop into
heart, lung, or brain cells, or any cells that you desire, with
the proper manipulation.
3 2
The alleged advantage to using bone marrow stem cells is "the ability
to make tissues using stem cells from the person afflicted with the
disease. ' 3° 3  These "familiar" cells would hopefully forego the
problems associated with the body attacking the "foreign" fetal tissue
cells. Consequently, some therapeutic companies are working on ways
to make bone marrow stem cell use more effective. 304 In fact, another
claimed source of stem cells that would possibly avoid the rejection of
foreign tissue complications, uses a more accessible and available
source - human fat.3 0 5
Regardless of the potential benefits and advancements made
regarding bone marrow stem cells, potential tissue sources from ectopic
pregnancies, stillbirths and spontaneous abortions are problematic
because they are "neither plentiful nor reliable .. . [and] their quality
and safety is questionable, making them less than optimal for research
and therapy." 30 6 It should be noted that:
300 See Fetal Tissue & Embryo Research, (May 25, 2001), at http://www.rtl.org/html/
fetal tissue embryo research.html.
301 See Daniel Kennelly, Fed Funded Fetal Tissue Research Rekindles Controversy,
(Apr. 29, 1999) at http://www.cnsnews.org/InDepth/archive/199904/IND 19990429d.html.
302 See Pellegrino, supra note 172..
303 See Fetal Tissue & Embryo Research, supra note 300.
304 See Dan Ferber, Ph.D., reviewed by Dr. Aman Shah, Stem-Cell Therapies Inch Their
Way Closer to the Clinic - But First Treatments Still Several Years Away (Aug. 18, 2000), at
http://my.webmd.com/content/article/1728.60509.
305 See Fetal Tissue & Embryo Research, supra note 300.
306 See Donating Fetal Tissue for Medical Treatment and Research, supra note 222.
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"Spontaneous abortions generally occur in the first
trimester of pregnancy. It is preceded by in utero fetal
death and detachment from the uterine wall. Typically 2-3
weeks later the conceptus is expelled from the uterus. This
long delay renders the tissue of most all spontaneous
abortions unsuitable for transplantation, primarily due to
the anoxic conditions the fetal tissues must endure. It
should also be noted that the majority of spontaneous
abortions occur outside a medical setting, making tissue
retrieval extremely difficult at best."
307
Therefore, science cannot rely on these avenues for the necessary
tissue, and must look elsewhere for other sources and technologies for
research specimens.
Consequently, the technological possibility of cloning becomes an
alternative source of tissue; however, also attached are heavily debated
ethical and moral considerations. "Many scientists believe that cloning
stem cells from [human] embryos holds great promise as a way to
develop treatments -- and possibly cures; '[s]ome people consider it
tantamount to creating human life with the intention of killing it;
[while] [o]thers fear this medical research will inevitably lead to the
actual cloning of human beings," ' 30 8 "will lead us farther down the road
to cloning people in the attempt to create 'perfect' babies."
30 9
However, John Gearhart, Ph.D., and other panelists at the AAAS
symposium "emphasized the need to clear up several public
misconceptions about the technology."3 10 They clarified that "[u]sing
human stem cells for research is not human cloning because the cells
can't generate a human being... [a]nd none of the technologies will
enable humans to live forever." 311  While both therapeutic and
reproductive cloning processes involve the extraction of living DNA
cells from an original host and implantation of it within the nucleus of a
donor cell, the cloning of a living, breathing person, i.e., reproductive
cloning, can only occur if the genetic material is transferred into a
307 See Patricia Schrock, Fetal Tissue Transplantation (Winter 1997), at
http://www.hsc.missouri.edu/-shrp/radsci/fetal/fetal I .html.
308 See Gina Shaw, reviewed by Dr. Craid H. Kliger, Cloning: How Far Should We Go?,
(Sept. 29, 2000), at http://my.webmd.corncontent/article/1691.50856.
309 See Pence, supra note 191.
310 See Dan Ferber, Ph.D., Ethicists Divided Over Human Embryo Research - Existing
Cells OK to Use, but Don't Make New Ones, Some Say (Feb. 22, 2000), at
http://my.webmd.com/content/article/1 78.55182.
311 id.
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surrogate mother where it would grow in a fully functioning human
being. Ultimately, this transference of this material to a womb is not a
component of the therapeutic cloning process, only involves the
growing of human cells and tissues, and therefore is not considered
human cloning.
312
A "series of recent reports show that research into this area of
medicine is moving at an incredible pace.' '313 "However, experts say
treatments derived from embryonic stem cells are at a much earlier
stage of the game, and until then, studies on the much less disputed
stem cells from adult humans have raised hopes of new treatments to
regrow or replace diseased tissue." 314  Furthermore, patients will
unlikely reap the benefits from these studies in the immediate future
because much more work needs to be done. 315 Annemarie Mosely,
M.D., Ph.D., and CEO of Osiris Therapeutics in Baltimore, agreed that
medical treatments using stem cells from embryos had a long road
ahead of them.316 Yet, "other researchers say that the first stem cell
derived therapies could show up in the clinic within five years." 317
CONCLUSION
Fetal tissue research and transplantation show great promise for
potentially lifesaving treatments of many incurable, debilitating, and
life threatening diseases known to mankind. Because the fetal stem
cells can grow quickly and almost indefinitely in a laboratory setting,
they can provide a virtually endless supply of cells. These cells are
pluripotent and are self-replicating "so you can create many, many cells
from a single source. For research purposes you don't need a new
embryo for every experiment." 318 Both researchers and patients hope
that fetal tissue transplants become as common and effective as the
transplants of organs, which once seemed to only be a figment of a
scientist's imagination. But in order to reach this goal, the unique
properties of fetal tissue are needed, not only because of the ability of
312 Ethical Implications of Cloning, at http://ece.oregonstate.edu/-henderob/cloning.htm.
313 See Dan Ferber, Ph.D., reviewed by Dr. Aman Shah, Stem-Cell Therapies Inch Their
Way Closer to the Clinic - But First Treatments Still Several Years Away (Aug. 18, 2000), at
http://my.webmd.com/content/article/i1728.60509.
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the cells to grow fast, but because there is less of a chance of rejection
than adult tissue specimens. Additionally, since alternative sources of
tissue have not been fully developed, sufficiently studied or adequately
tested, research using fetal tissue should be used to its fullest curative
potential.
However, one cannot deny that discussion of the potential
therapeutic uses of human fetal tissue arouses strong emotions and is
the foreground for many ethical disputes. Although its use may have
vocal detractors, it also has powerful and well known backers. Many
scientists, doctors, organizations and even actors voice their opinions in
the national debate for fetal tissue research and transplantation. There
are also those who acknowledge that a woman's decision to donate
human tissue is a complicated decision, but is one reflecting
"generosity, courage, and the hope that some humanitarian good may
come out of an unintended pregnancy." '319 Additionally, while some
opponents portray the use and acquisition of specific tissue parts as
cold, detached, and economically driven, it is important to invalidate
this fallacious depiction by explaining the necessity for the tissue's
itemization, and the standards for its collection and allocation. Even
though these practices may appear to be very businesslike, certain
protocol is essential to regulating its use and preventing fraud and
abuse within the fetal tissue research and distribution community.
Some proponents of fetal tissue research even argue:
"The real question is not whether there is any danger of
abuse, but instead, whether the risk of abuse is so great that
millions of Americans with [incurable and untreatable]
diseases should lose the chance of a potential cure. Is the
risk of a slippery slope so great that it should hold hostage
such an important area of medical research? Can we really
afford to throw away the promise these techniques offer to
treat ailments that have previously been untreatable? Do
we have the right to?"32
The answer is no, especially since so many advances have been made
and the potential for remedies and treatment is so imminent. It would
be wonderfully advantageous to have the cures for Parkinson's Disease,
Alzheimer's, Diabetes, Spinal Cord Injuries, and AIDS, just to name a
319 See Donating Fetal Tissue for Medical Treatment and Research, supra note 222.
120 See Pence, supra note 191.
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few, become readily available through this progressive research. One
has to ask how ethical is it to deny these people who suffer day-in and
day-out with their diseases, especially when the technology is at our
fingertips?
"The roadway traveled by those who make ethical
decisions is unavoidably a slippery slope. To traverse it
successfully requires placement of wedges at the right
places, in order to restrict or stop travel at those points
where one is most likely to fail.. .It would be morally
wrong to forego the benefits of a promising treatment for
fear of slipping on the slope."32'
Currently, fetal tissue research is integral for potential cures, and there
is no convincing evidence that it can be deemed an abortion lure.
Therefore, let research continue on the road of revolutionary, scientific
discovery, hopefully picking up along the way the technology to end
the pain of so many suffering beyond that path of medical
enlightenment. At present, it is their most promising hope for a healthy
life.
321 See Patricia Schrock, Fetal Tissue Transplantation
http://www.hsc.missouri.edu/-shrp/ radsci/fetal/fetal .html.
(Winter 1997), at
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